Elixinol Wellness Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	1.3yrs

Recente managementupdates

Recent updates

CEO

Elixinol Wellness heeft geen CEO, of we hebben geen gegevens over hen.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Josephine Lorenz	Group Chief Financial Officer	2.6yrs	AU$342.31k	0.18% € 12.0k
Glen Zurcher	Account Director of Investor Relations Department	no data	geen gegevens	geen gegevens
Natalie Butler	Head of Marketing & Executive Director	less than a year	geen gegevens	0.066% € 4.3k
Melanie Leydin	Company Secretary	less than a year	geen gegevens	geen gegevens

0.7yrs

Gemiddelde duur

Ervaren management: Het managementteam van E8M wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.7 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Natalie Butler	Head of Marketing & Executive Director	less than a year	geen gegevens	0.066% € 4.3k
David Fenlon	Independent Non-Executive Chairman	2.7yrs	AU$118.28k	0.29% € 18.5k
Pauline Gately	Non-Executive Director	1.3yrs	AU$32.63k	0.73% € 47.1k

1.3yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van E8M wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw bestuur.

Elixinol Wellness Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Elixinol Wellness Limited Announces Resignation of Tai Phan as Joint Company Secretary, Effective 25 October 2024

Elixinol Wellness Limited, Annual General Meeting, May 30, 2024

Less than half of directors are independent

Elixinol Wellness Limited Announces Company Secretary Changes

Elixinol Wellness Limited Announces Management Changes

Elixinol Wellness Limited, Annual General Meeting, May 26, 2022

Recent updates

Elixinol Wellness Limited Announces Resignation of Tai Phan as Joint Company Secretary, Effective 25 October 2024

Elixinol Wellness Limited, Annual General Meeting, May 30, 2024

Elixinol Wellness Limited (ASX:EXL) completed the acquisition of Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF).

Full year 2023 earnings released: AU$0.016 loss per share (vs AU$0.033 loss in FY 2022)

Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million.

Elixinol Wellness Limited has filed a Follow-on Equity Offering in the amount of AUD 3.164358 million.

Less than half of directors are independent

First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.023 loss in 1H 2022)

New major risk - Shareholder dilution

New minor risk - Financial data availability

Elixinol Wellness Limited has completed a Follow-on Equity Offering in the amount of AUD 1 million.

Elixinol Wellness Limited Announces Company Secretary Changes

Full year 2022 earnings released: AU$0.033 loss per share (vs AU$0.054 loss in FY 2021)

Elixinol Wellness Limited (ASX:EXL) agreed to acquire The Sustainable Nutrition Group Ltd (ASX:TSN).

First half 2022 earnings released: AU$0.023 loss per share (vs AU$0.035 loss in 1H 2021)

Elixinol Wellness Limited Announces Management Changes

Elixinol Wellness Limited, Annual General Meeting, May 26, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Elixinol Announces Launch of Two New Innovative CBD Products Focused on Supporting Sleep

Elixinol Expands Product Line With First CBD Pet Collection

First half 2021 earnings released: AU$0.035 loss per share (vs AU$0.60 loss in 1H 2020)

Elixinol Global Limited Introduces the First CBD Capsules Powered by Ginfort

Elixinol Global Limited Appoints Frank Otto as Non-Executive Director of its Board

Elixinol Global Limited Appoints Kim Bradley-Ware as Joint Company Secretary

Full year 2020 earnings released: AU$0.58 loss per share (vs AU$0.50 loss in FY 2019)

Elixinol Global Limited announced that it expects to receive AUD 8.195575 million in funding

Elixinol Launches Good Mood CBD Gummies Just in Time for 2020 Election Day

Elixinol Global Limited(ASX:EXL) dropped from S&P/ASX Emerging Companies Index

First half earnings released

Elixinol Global Limited(ASX:EXL) dropped from S&P Global BMI Index

CEO

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur